# Olmesartan Medoxomil Versus Losartan in Patients With Hypertension

> **NCT00857285** · PHASE3 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 130 (actual)

## Conditions studied

- Essential Hypertension

## Interventions

- **DRUG:** olmesartan medoxomil
- **DRUG:** losartan potassium

## Key facts

- **NCT ID:** NCT00857285
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** 2003-08
- **Final completion:** 2003-09
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2009-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00857285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00857285, "Olmesartan Medoxomil Versus Losartan in Patients With Hypertension". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00857285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*